Multiplex assays allow researchers to measure multiple biomarkers simultaneously, offering the advantage of harvesting more insightful data to inform better decision-making, accelerate research, and increase the probability of discovery. Enabling biomarker discovery and screening with FirePlex Multiplexed Assays features the expertise of Dr Paul Wylie.
In this webinar with Dr Paul Wylie, Director of Multiplex at Abcam, you will learn about High-Throughput FirePlex-384 and 1536 immunoassays for discovery, screening and profiling projects. The webinar includes a case study on a recent publication that used FirePlex 384 in the characterisation of iPSC-derived macrophage cell line.
According to Abcam, the benefits of High-Throughput FirePlex 384 and 1536 include a no-wash automation-friendly assay workflow; it utilises your existing equipment (High Content Imager); it harvests more data at an earlier stage to improve decision making; and recombinant rabbit monoclonal antibodies (high specificity).